Cangene, created in 1984 (United States), from 22 sister brands and 4958 competing brands. Cangene is owned by Emergent Biosolutions, listed on the stock exchange of New York Cangene is part of the Drug Manufacturers activity sector.

Cangene is a brand of Emergent Biosolutions (EBS) Share price

Share price and profitability of the share Emergent Biosolutions (Cangene)

Buy Emergent Biosolutions share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 2.59

Portfolio valuation
Emergent Biosolutions (Cangene) over 5 years* USD 0.13

Stock market history Emergent Biosolutions (Cangene)